InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Summit Partners Growth Equity Fund IX-A, L.P.. Director active across 2 companies, notably LifeStance Health Group, Inc.. Cumulatively, 5 reports have been published. Split: 0 buy · 5 sells. Total volume traded: €91.7m. Activity tracked since 14 June 2021. The latest transaction was disclosed on 24 May 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
3,802,345 shares@ US$5.89100.0% of flowCommon StockSEC:0000950170-24-066078:0
1,140,704 shares@ US$17.010.56% mcap22.9% of flowCommon StockSEC:0001179110-21-007118:0
1,140,704 shares@ US$17.0122.9% of flowCommon StockSEC:0001179110-21-007118
1,368,844 shares@ US$17.0127.1% of flowCommon StockSEC:0001179110-21-006787
1,368,844 shares@ US$17.010.66% mcap27.1% of flowCommon StockSEC:0001179110-21-006787:0
5 of 5 declarations
